Solvay is a multi-specialty chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability. Its lightweighting materials enhance cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 27,000 employees in 58 countries. Net sales were € 10.9 billion in 2016, with 90% from activities where Solvay ranks among the world’s top 3 leaders. Solvay SA (SOLB.BE) is listed on Euronext Brussels and Paris (Bloomberg: SOLB.BB - Reuters: SOLB.BR) and in the United States its shares (SOLVY) are traded through a level-1 ADR program.
According to the Belgian transparency legislation in force (Law of May 2, 2007), SOLVAC SA, located at Rue des Champs Elysées 43 – 1050 Brussels – Belgium, has notified Solvay SA that on November 15, SSOM crossed upwards the statutory declaration threshold of 3% of the existing voting rights emitted by Solvay SA, whereby the combined holding by Solvac and SSOM reached 33.71% of the existing voting rights.
SOLVAC SA is presumed to exercise de facto control over Solvay SA, and therefore SSOM, on the basis of Article 5, §3, 2nd paragraph of the Belgian companies code.
The declaration by SOLVAC SA is published in the Investor Relations Section of Solvay's website.